Autoimmune pancreatocholangitis, non-autoimmune pancreatitis and primary sclerosing cholangitis: A comparative morphological and immunological analysis

PLoS ONE

Volumn 3, Issue 7, 2008, Pages

  Esposito, Irene ^a,b   Born, Diana ^c   Bergmann, Frank ^c   Longerich, Thomas ^c   Welsch, Thilo ^c   Giese, Nathalia A ^c   Büchler, Markus W ^c   Kleeff, Jörg ^a   Friess, Helmut ^a   Schirmacher, Peter ^c  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR5; CXCL13 CHEMOKINE; IMMUNOGLOBULIN G4;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE PANCREATOCHOLANGITIS; BILIARY TRACT DISEASE; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; INFLAMMATORY INFILTRATE; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; PANCREATICODUODENECTOMY; PLASMA CELL; PRIMARY SCLEROSING CHOLANGITIS; REAL TIME POLYMERASE CHAIN REACTION; STROMA; T LYMPHOCYTE; CHOLANGITIS; IMMUNOLOGY; MIDDLE AGED; PANCREATITIS; PATHOLOGY; SCLEROSING CHOLANGITIS;

ADULT; AUTOIMMUNE DISEASES; CHOLANGITIS; CHOLANGITIS, SCLEROSING; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATITIS; PANCREATITIS, CHRONIC;

EID: 49749114314     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002539     Document Type: Article

References (42)

1. Sarles H, Sarles JC, Muratore R, Guien C (1961) Chronic inflammatory sclerosis of the pancreas-an autonomous pancreatic disease? Am J Dig Dis 6: 688-698.
2. Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, et al. (1995) Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 40: 1561-1568.
3. Finkelberg DL, Sahani D, Deshpande V, Brugge WR (2006) Autoimmune pancreatitis. N Engl J Med 355: 2670-2676.
4. van Buuren HR, Vleggaar FP, Willemien Erkelens G, Zondervan PE, Lesterhuis W, et al. (2006) Autoimmune pancreatocholangitis: a series of ten patients. Scand J Gastroenterol Suppl: 70-78.
5. Zen Y, Fujii T, Harada K, Kawano M, Yamada K, et al. (2007) Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology 45: 1538-1546.
6. Kojima M, Sipos B, Klapper W, Frahm O, Knuth HC, et al. (2007) Autoimmune pancreatitis: frequency, IgG4 expression, and clonality of T and B cells. Am J Surg Pathol 31: 521-528.
7. Okazaki K (2003) Autoimmune pancreatitis is increasing in Japan. Gastroenterology 125: 1557-1558.
8. Kwon S, Kim MH, Choi EK (2007) The diagnostic criteria for autoimmune chronic pancreatitis: it is time to make a consensus. Pancreas 34: 279-286.
9. Okazaki K, Chiba T (2002) Autoimmune related pancreatitis. Gut 51: 1-4.
10. Ota M, Katsuyama Y, Hamano H, Umemura T, Kimura A, et al. (2007) Two critical genes (HLA-DRB1 and ABCF1)in the HLA region are associated with the susceptibility to autoimmune pancreatitis. Immunogenetics 59: 45-52.
11. Uchida K, Okazaki K, Nishi T, Uose S, Nakase H, et al. (2002) Experimental immune-mediated pancreatitis in neonatally thymectomized mice immunized with carbonic anhydrase II and lactoferrin. Lab Invest 82: 411-424.
12. Nishimori I, Miyaji E, Morimoto K, Nagao K, Kamada M, et al. (2005) Serum antibodies to carbonic anhydrase IV in patients with autoimmune pancreatitis. Gut 54: 274-281.
13. Okazaki K, Uchida K, Ohana M, Nakase H, Uose S, et al. (2000) Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. Gastroenterology 118: 573-581.
14. Aparisi L, Farre A, Gomez-Cambronero L, Martinez J, De Las Heras G, et al. (2005) Antibodies to carbonic anhydrase and IgG4 levels in idiopathic chronic pancreatitis: relevance for diagnosis of autoimmune pancreatitis. Gut 54: 703-709.
15. Kleeff J, Welsch T, Esposito I, Lohr M, Singer R, et al. (2006) [Autoimmune pancreatitis a surgical disease?]. Chirurg 77: 154-165.
16. Choi EK, Kim MH, Lee TY, Kwon S, Oh HC, et al. (2007) The sensitivity and specificity of serum immunoglobulin G and immunoglobulin G4 levels in the diagnosis of autoimmune chronic pancreatitis: Korean experience. Pancreas 35: 156-161.
17. Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, et al. (2001) High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 344: 732-738.
18. Ghazale A, Chari ST, Smyrk TC, Levy MJ, Topazian MD, et al. (2007) Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol 102: 1646-1653.
19. Deshpande V, Mino-Kenudson M, Brugge W, Lauwers GY (2005) Autoimmune pancreatitis: more than just a pancreatic disease? A contemporary review of its pathology. Arch Pathol Lab Med 129: 1148-1154.
20. Amft N, Curnow SJ, Scheel-Toellner D, Devadas A, Oates J, et al. (2001) Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjogren's syndrome. Arthritis Rheum 44: 2633-2641.
21. Aust G, Sittig D, Becherer L, Anderegg U, Schutz A, et al. (2004) The role of CXCR5 and its ligand CXCL13 in the compartmentalization of lymphocytes in thyroids affected by autoimmune thyroid diseases. Eur J Endocrinol 150: 225-234.
22. Carlsen HS, Baekkevold ES, Johansen FE, Haraldsen G, Brandtzaeg P (2002) B cell attracting chemokine I (CXCL13) and its receptor CXCR5 are expressed in normal and aberrant gut associated lymphoid tissue. Gut 51: 364-371.
23. Shi K, Hayashida K, Kaneko M, Hashimoto J, Tomita T, et al. (2001) Lymphoid chemokine B cell-attracting chemokine-1 (CXCL13) is expressed in germinal center of ectopic lymphoid follicles within the synovium of chronic arthritis patients. J Immunol 166: 650-655.
24. Zamboni G, Luttges J, Capelli P, Frulloni L, Cavallini G, et al. (2004) Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch 445: 552-563.
25. Esposito I, Friess H, Kappeler A, Shrikhande S, Kleeff J, et al. (2001) Mast cell distribution and activation in chronic pancreatitis. Hum Pathol 32: 1174-1183.
26. Esposito I, Menicagli M, Funel N, Bergmann F, Boggi U, et al. (2004) Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma. J Clin Pathol 57: 630-636.
27. Welsch T, Kleeff J, Esposito I, Buchler MW, Friess H (2006) Autoimmune pancreatitis associated with a large pancreatic pseudocyst. World J Gastroenterol 12: 5904-5906.
28. Chari ST, Smyrk TC, Levy MJ, Topazian MD, Takahashi N, et al. (2006) Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol 4: 1010-1016; quiz 1934.
29. Kim KP, Kim MH, Kim JC, Lee SS, Seo DW, et al. (2006) Diagnostic criteria for autoimmune chronic pancreatitis revisited. World J Gastroenterol 12: 2487-2496.
30. Okazaki K, Kawa S, Kamisawa T, Naruse S, Tanaka S, et al. (2006) Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol 41: 626-631.
31. Pearson RK, Longnecker DS, Chari ST, Smyrk TC, Okazaki K, et al. (2003) Controversies in clinical pancreatology: autoimmune pancreatitis: does it exist? Pancreas 27: 1-13.
32. Church NI, Pereira SP, Deheragoda MG, Sandanayake N, Amin Z, et al. (2007) Autoimmune pancreatitis: clinical and radiological features and objective response to steroid therapy in a UK series. Am J Gastroenterol 102: 2417-2425.
33. Deshpande V, Chicano S, Finkelberg D, Selig MK, Mino-Kenudson M, et al. (2006) Autoimmune pancreatitis: a systemic immune complex mediated disease. Am J Surg Pathol 30: 1537-1545.
34. Hamano H, Kawa S (2006) Are there any other organs in which autoimmune pancreatitis-associated lesions remain to be identified? Intern Med 45: 883-884.
35. Bjornsson E, Chari ST, Smyrk TC, Lindor K (2007) Immunoglobulin G4 associated cholangitis: description of an emerging clinical entity based on review of the literature. Hepatology 45: 1547-1554.
36. Zen Y, Harada K, Sasaki M, Sato Y, Tsuneyama K, et al. (2004) IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol 28: 1193-1203.
37. Nishino T, Oyama H, Hashimoto E, Toki F, Oi I, et al. (2007) Clinicopathological differentiation between sclerosing cholangitis with autoimmune pancreatitis and primary sclerosing cholangitis. J Gastroenterol 42: 550-559.
38. Aoki S, Nakazawa T, Ohara H, Sano H, Nakao H, et al. (2005) Immunohistochemical study of autoimmune pancreatitis using anti-IgG4 antibody and patients' sera. Histopathology 47: 147-158.
39. Zhang L, Notohara K, Levy MJ, Chari ST, Smyrk TC (2007) IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis. Mod Pathol 20: 23-28.
40. Luparello C, Sheterline P, Pucci-Minafra I, Minafra S (1991) A comparison of spreading and motility behaviour of 8701-BC breast carcinoma cells on type I, I-trimer and type V collagen substrata. Evidence for a permissive effect of type I-trimer collagen on cell locomotion. J Cell Sci 100 (Pt 1): 179-185.
41. Esposito I, Penzel R, Chaib-Harrireche M, Barcena U, Bergmann F, et al. (2006) Tenascin C and annexin II expression in the process of pancreatic carcinogenesis. J Pathol 208:673-685.
42. Bachem MG, Schneider E, Gross H, Weidenbach H, Schmid RM, et al. (1998) Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology 115: 421-432.